Amgen Optimistic About 2020 Despite COVID-19 Impacts

Q1 1st First Quarter Period Stock Market Ticker Words 3d Illustration
Amgen's $6.2bn in Q1 revenue exceeded analyst consensus of $6bn • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Earnings

More from Business